Desensitization of Capsaicin-evoked Neuropeptide Release--influence of Ca2+ and Temperature
Overview
Authors
Affiliations
Capsaicin-induced stimulation and desensitization of neuropeptide release from primary afferent neurons was investigated in the rat urinary bladder in-vitro. The capsaicin (5 min contact time)-evoked release of calcitonin gene-related peptide-like immunoreactivity (CGRP-IR) was dose-dependent; threshold to produce detectable release was 0.1 mumol/l, the EC50 was 0.17 mumol/l. Pre-exposure of tissues to capsaicin (0.1-1.0 mumol/l, 5 min contact time) caused a dose-dependent reduction of the amount of CGRP-IR which was released by a second exposure to capsaicin. At 0.1 and 0.3 mumol/l, capsaicin was less effective to inhibit the subsequent K(+)-evoked release than that evoked by a second capsaicin exposure. Pre-exposure to 1 mumol/l capsaicin completely prevented subsequent K(+)- or capsaicin-evoked release of CGRP-IR. Exposure of the preparation to capsaicin (0.3 mumol/l) in a Ca2(+)-free, EDTA-containing medium did not produce release of CGRP-IR. A subsequent stimulation with capsaicin in a 2.5 mmol/l Ca2(+)-containing superfusion solution was not less effective to release CGRP-IR than in tissues which had not been pre-exposed to capsaicin. At 18 degrees C, the capsaicin-evoked release of CGRP-IR was reduced to 20% of the value obtained by the same dose (0.3 mumol/l for 5 min) of capsaicin at 37 degrees C. Comparison of the desensitizing effect of 0.3 and 0.1 mumol/l capsaicin at 18 degrees C and 37 degrees C, respectively, showed significant inhibition of desensitization at 18 degrees C.(ABSTRACT TRUNCATED AT 250 WORDS)
Abdel-Salam O, Mozsik G Neurochem Res. 2023; 48(11):3296-3315.
PMID: 37493882 PMC: 10514110. DOI: 10.1007/s11064-023-03983-z.
Calcitonin gene-related peptide and pain: a systematic review.
Schou W, Ashina S, Amin F, Goadsby P, Ashina M J Headache Pain. 2017; 18(1):34.
PMID: 28303458 PMC: 5355411. DOI: 10.1186/s10194-017-0741-2.
NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.
Gear R, Bogen O, Ferrari L, Green P, Levine J Neuroscience. 2013; 257:139-48.
PMID: 24188792 PMC: 3947912. DOI: 10.1016/j.neuroscience.2013.10.061.
Quiroz U, Morales-Ledesma L, Moran C, Trujillo A, Dominguez R Endocrine. 2013; 46(2):309-17.
PMID: 24122121 DOI: 10.1007/s12020-013-0055-3.
Chen T, Corcos J, Camel M, Ponsot Y, Tu L Int Urogynecol J Pelvic Floor Dysfunct. 2005; 16(4):293-7.
PMID: 15818465 DOI: 10.1007/s00192-005-1307-4.